InsidersTradesSigma
Follow the HK이노엔 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, HK이노엔 has published 34 public disclosures. Market capitalisation: €1,029.8bn. The latest transaction was reported on 1 July 2026 (Sale). Among the most active insiders: 국민연금공단. The full history is free.
33
Insider Decl.
n/a
Thresholds
€55,372
11 ops.
Buy Volume
n/a
17 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate HK이노엔 Buy (bullish), based on 12 analysts. Average price target: ₩65,500.
35Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,801 of 29,056 companies
56.6
score / 100
Value65
Quality49
FCF yld6.1%
Earn yld6.1%
EV/EBITDA11.5x
ROE3.9%
Gross mgn46%
Net mgn7.1%
Debt/EBITDA3.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 July 2026
Declarations34 total
Other
319,805 sharesKRXDART:20240809000510
25 of 34 declarations
Acerca de HK이노엔
HK이노엔 es una empresa que opera en el sector de la salud y farmacéutico, cotiza en la bolsa XKRX. Se centra en el desarrollo y la comercialización de productos farmacéuticos innovadores.